CRNX Disposition Disclosure
Betz Stephen F. · SEC Form 4 · Filed Sep 1, 2026
Disposition
Calculated transaction value
$3.36M
Betz Stephen F. Chief Scientific Officer
CRNX
Transaction date
Sep 1, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed same day
CRNX daily price context
Close on/before transaction
$84.95
Sep 1, 2026
Close before public filing
$84.95
Aug 31, 2026
Return since public filing
0.0%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 56,250 shares @ $59.81
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001628280-26-059884
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$59.72M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $4.95M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $927.15K |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $7.19M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $6.77M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $7.52M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $5.64M |
| Crinetics Pharmaceuticals, Inc. CRNX Current | Disposition | Sep 1, 2026 | $3.36M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $3.74M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $5.93M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $5M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $3.61M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $3.13M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $1.94M |